ACRX - Acelrx Pharmaceuticals Inc
Close
0.86
0.860 100.000%
Share volume: 0
Last Updated: Tue 09 Jan 2024 09:24:44 PM CET
Pharmaceutical Preparation Manufacturing :
2.75%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
29%
Profitability
28%
Dept financing
23%
Liquidity
55%
Performance
25%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
10.48%
Return on assets
-11.79%
Return on sales
-1623.21%
Return on invested capital
259.97%
Total debt ratio
137.37%
Debt ratio change over timeo
-0.96%
Current Ratio
5.69%
Quick Ratio
5.55%
Cash Position Ratio
4.09%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
29.91%
Return on assets
-14.82%
Return on sales
-2398.02%
Return on invested capital
-281.6%
Total debt ratio
158.24%
Debt ratio change over timeo
-1.77%
Current Ratio
4.85%
Quick Ratio
4.64%
Cash Position Ratio
1.46%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
10.99%
Return on assets
-10.14%
Return on sales
-233.72%
Return on invested capital
-280.99%
Total debt ratio
189.22%
Debt ratio change over time
-1.42%
Current Ratio
2.96%
Quick Ratio
2.8%
Cash Position Ratio
1.33%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-122.99%
Return on assets
-99.83%
Return on sales
37.16%
Return on invested capital
-33.11%
Total debt ratio
-96.34%
Debt ratio change over time
-0.96%
Current Ratio
-0.49%
Quick Ratio
-0.48%
Cash Position Ratio
-0.11%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACRX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 10.48% | 0% | 0% | 29.06% |
| Return on assets | -11.79% | 0% | 0% | -9.75% |
| Return on sales | -1623.21% | 0% | 0% | -1469.44% |
| Return on invested capital | 259.97% | 0% | 0% | 47.78% |
| Profitability | 34% | 0% | 50% | 30% |
| Total debt ratio | 137.37% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.96% | 0% | 0% | 19.02% |
| Dept financing | 19% | 0% | 0% | 50% |
| Current Ratio | 4.85% | 0% | 0% | 5.9% |
| Quick Ratio | 4.64% | 0% | 0% | 5.9% |
| Cash Position Ratio | 1.46% | 0% | 0% | 5.68% |
| Liquididy | 75% | 0% | 0% | 63% |
| Short-term ratios | ACRX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 29.91% | 0% | 0% | -16.12% |
| Return on assets | -14.82% | 0% | 0% | -14.95% |
| Return on sales | -2398.02% | 0% | 0% | -3498.94% |
| Return on invested capital | -281.6% | 0% | 0% | 96.56% |
| Profitability | 25% | 0% | 50% | 25% |
| Total debt ratio | 158.24% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.77% | 0% | 0% | 0.09% |
| Dept financing | 25% | 0% | 0% | 38% |
| Current Ratio | 4.85% | 0% | 0% | 5.9% |
| Quick Ratio | 4.64% | 0% | 0% | 5.9% |
| Cash Position Ratio | 1.46% | 0% | 0% | 5.68% |
| Liquididy | 47% | 0% | 0% | 75% |